Links
Archives
Thursday, June 29, 2006
Assessment of quality of life rather than survival benefit
1)Burris Clinical Benefit Response
Ref. 1
Ref. 2
2)EORTC
WHAT IS THE EORTC QLQ-C30?
The EORTC QLQ-C30 is a questionnaire developed to assess the quality of life of cancer patients. It is a copyrighted instrument, which has been translated and validated into 81 languages and is used in more than 3,000 studies worldwide. It is supplemented by disease specific modules e.g. Breast, Lung, Head & Neck, Oesophageal, Ovarian and Gastric Cancer, which are distributed from the Data Center. Other disease specific modules are under development but not yet validated. We have also developed a Satisfaction with Care measure (EORTC-IN-PATSAT32) and a Palliative Care questionnaire (QLQ-C15-PAL). These are also general questionnaires. Presently QLQ-C30 Version 3.0 is the most recent version and should be used for all new studies. Conditions for its use are dependent on whether it will be employed in an academic setting, in which case its distribution is free. Or if it is to be used in a study that is carried out or sponsored by the pharmaceutical industry, when its use is subject to a royalty fee. A royalty fee is required per clinical study. The funds that are generated through the copyright arrangement are used exclusively to support the on-going research of the QLG on the development and refinement of quality of life instruments. For further information contact the Quality of Life Unit.
PDF ver.
Ref. 1
Ref. 2
2)EORTC
WHAT IS THE EORTC QLQ-C30?
The EORTC QLQ-C30 is a questionnaire developed to assess the quality of life of cancer patients. It is a copyrighted instrument, which has been translated and validated into 81 languages and is used in more than 3,000 studies worldwide. It is supplemented by disease specific modules e.g. Breast, Lung, Head & Neck, Oesophageal, Ovarian and Gastric Cancer, which are distributed from the Data Center. Other disease specific modules are under development but not yet validated. We have also developed a Satisfaction with Care measure (EORTC-IN-PATSAT32) and a Palliative Care questionnaire (QLQ-C15-PAL). These are also general questionnaires. Presently QLQ-C30 Version 3.0 is the most recent version and should be used for all new studies. Conditions for its use are dependent on whether it will be employed in an academic setting, in which case its distribution is free. Or if it is to be used in a study that is carried out or sponsored by the pharmaceutical industry, when its use is subject to a royalty fee. A royalty fee is required per clinical study. The funds that are generated through the copyright arrangement are used exclusively to support the on-going research of the QLG on the development and refinement of quality of life instruments. For further information contact the Quality of Life Unit.
PDF ver.
Posted by: Ds20040999 / 7:45 AM 
